Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C-Reference-Cited by-同舟云学术

Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C

Published:2021-03 Issue:3 Volume:159 Page:1197-1207
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Certain Marie-Caroline,Chaumais Marie-Camille,Jaïs Xavier,Savale Laurent,Seferian Andrei,Parent Florence,Georges Marjolaine,Favrolt Nicolas,Bourdin Arnaud,Boissin Clément,Cottin Vincent,Traclet Julie,Renard Sébastien,Noel Violaine,Picard François,Girerd Barbara,Ghigna Maria-Rosa,Perros Frédéric,Sitbon Olivier,Bonniaud Philippe,Humbert Marc,Montani David

Funder

Agence Nationale de Sécurité du Médicament et des Produits de Santé

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference24 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. Haemodynamic definitions and updated clinical classification of pulmonary hypertension;Simonneau;Eur Respir J,2019

3. Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences;Montani;Semin Respir Crit Care Med,2009

4. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives;Humbert;Eur Respir J,2019

5. Pathologic assessment of vasculopathies in pulmonary hypertension;Pietra;J Am Coll Cardiol,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definition, classification and diagnosis of pulmonary hypertension;European Respiratory Journal;2024-08-29

2. Inhalation of hydrogen gas protects against mitomycin-induced pulmonary veno-occlusive disease;Respiratory Research;2024-07-16

3. Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors;European Respiratory Journal;2024-05-02

4. Characteristics and outcomes of gemcitabine-associated pulmonary hypertension;ERJ Open Research;2024-05

5. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023);Eurasian heart journal;2024-03-11